| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/14/1999 | CN1222369A Compound asthma capsule and its preparation |
| 07/14/1999 | CN1222368A Preparation of ointment for curing burns and scalds and promoting tissue generation |
| 07/14/1999 | CN1222364A Serial medicines for curing cancer through oral taking, dressing and medicated diet and preparation thereof |
| 07/14/1999 | CN1222363A Preparation of Chinese medicine for curing cardiac and cerebral diseases atomized by oxygen and its preparation process |
| 07/14/1999 | CN1222361A Zhongluo capsule as hair tonic |
| 07/14/1999 | CN1222360A Chinese medicine 'Ganyusan' for treatment of hepatosis |
| 07/14/1999 | CN1222357A Capsule of American ginseng and astragalus membranaceus |
| 07/14/1999 | CN1222355A Ginseng royal jelly without delaminating deposition and its preparation |
| 07/14/1999 | CN1222354A Spray oil to erect penis |
| 07/14/1999 | CN1222353A 二次血源 Second blood |
| 07/14/1999 | CN1222352A Preparation of high-immunity pig-sourced serum resisting main infectious diseases of chicken |
| 07/14/1999 | CN1044121C Method for isolating coagulation factors VIII complex |
| 07/14/1999 | CN1044090C Medicine for treating lithangiuria and process for preparing same |
| 07/13/1999 | US5922847 Exposure to antibody or fragments binding to epitope on receptor recognized by the factor, separating binding cells |
| 07/13/1999 | US5922841 Recombinantly produced transferrin receptor of haemophilus |
| 07/13/1999 | US5922836 Mammaglobin antigens |
| 07/13/1999 | US5922773 Treatment with n-methyl-d-aspartate antagonist for vision defects |
| 07/13/1999 | US5922598 Reducing tissue immunogenicity by induction of apoptosis |
| 07/13/1999 | US5922597 The benefit of obtaining a pure population of stem cells is most readily recognized in the field of gene therapy. |
| 07/13/1999 | US5922590 Hic-1 is a marker which can be used diagnostically, prognostically and therapeutically over the course of such disorders. |
| 07/13/1999 | US5922587 Psuedonaja textilis venom, used for the detection of lupus anticoagulant(la); increased clotting activity in presence of calcium ions, phospholipids, reduced activity in the presence of la, unaffected by a deficiency in clotting factors |
| 07/13/1999 | US5922562 Nucleic acids encoding transferrin receptors |
| 07/13/1999 | US5922375 Probiotic Bifidobacterium strain |
| 07/13/1999 | US5922359 Skin treatment compositions comprising unoxidized nerve tissue |
| 07/13/1999 | US5922344 Product for prevention of respiratory virus infection and method of use |
| 07/13/1999 | US5922324 Adjusting the ph of propolis to 5.5-7.0 to improve the water-solubility |
| 07/13/1999 | US5922323 Transferrin receptor genes and immunogenic compositions derived therefrom |
| 07/13/1999 | US5922317 Accelerated gas removal from divers' tissues utilizing gas metabolizing bacteria |
| 07/13/1999 | US5922278 Method and apparatus for inactivating contaminants in biological fluid |
| 07/13/1999 | US5921987 Articular cartilage transplant instrument set |
| 07/13/1999 | CA2135999C Biotherapeutic cell-coated microspheres |
| 07/13/1999 | CA2000153C Antidote |
| 07/13/1999 | CA1340649C Purified follicle stimulating hormone |
| 07/13/1999 | CA1340641C Recombinant lymphotoxin |
| 07/08/1999 | WO1999034007A1 Delivery of polypeptide-encoding plasmid dna into the cytosol of macrophages by attenuated suicide bacteria |
| 07/08/1999 | WO1999033981A2 Human signal peptide-containing proteins |
| 07/08/1999 | WO1999033484A1 Production process for intravenous immune serum globulin and resultant product |
| 07/08/1999 | WO1999033479A1 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 07/08/1999 | WO1999020739A3 Novel lactic acid bacteria species |
| 07/08/1999 | WO1999019466A3 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 07/08/1999 | WO1999018226A3 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 07/08/1999 | WO1998055594A3 Methods for chondrocyte growth and differentiation |
| 07/08/1999 | CA2317111A1 Delivery of polypeptide-encoding plasmid dna into the cytosol of macrophages by attenuated suicide bacteria |
| 07/08/1999 | CA2315790A1 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 07/08/1999 | CA2315617A1 Human signal peptide-containing proteins |
| 07/08/1999 | CA2281938A1 Production process for intravenous immune serum globulin and resultant product |
| 07/07/1999 | EP0927244A1 Semi-allogeneic cell hybrids as preventive and therapeutic vaccines for cancer and aids |
| 07/07/1999 | EP0927196A1 Polymers containing polysaccharides such as alginates or modified alginates |
| 07/07/1999 | EP0927195A2 Process for producing a plasma protein-containing medicament |
| 07/07/1999 | EP0927052A1 Bladder submucosa seeded with cells for tissue reconstruction |
| 07/07/1999 | EP0927043A1 Method for gene transfer to the central nervous system |
| 07/07/1999 | EP0927042A1 Prevention of gastrointestinal damage |
| 07/07/1999 | EP0927041A2 Treatment of diabetes |
| 07/07/1999 | EP0927040A1 Process to obtain oestrogens from mare's urine |
| 07/07/1999 | EP0927023A1 Composition for treating acne |
| 07/07/1999 | EP0926955A1 Conjugates useful in the treatment of prostate cancer |
| 07/07/1999 | EP0821595B1 Method for the microbial decontamination of blood platelets |
| 07/07/1999 | EP0759029B1 Modified milk growth factor |
| 07/07/1999 | EP0609437B1 Novel sphingoglycolipid and use thereof |
| 07/07/1999 | CN1222193A Extracellular matrix signalling molecules |
| 07/07/1999 | CN1221751A Extract of mammal eyes |
| 07/07/1999 | CN1221621A Blood platelet regenerating pills and its prepn. method |
| 07/07/1999 | CN1221616A Prescription, preparation of medicine for treating cancer and its instructions of taking medicine |
| 07/07/1999 | CN1221615A Instant powder for strengthening stomach and relieving dyspepsia |
| 07/06/1999 | US5919911 Monoclonal antibodies to stem cell factor receptors |
| 07/06/1999 | US5919908 Protein formulation comprising coagulation factor VIII or factor IX in an aqueous solution |
| 07/06/1999 | US5919904 Response regulator polypeptides; screening for bactericides |
| 07/06/1999 | US5919766 Storage stability by incorporating nonionic surfactant, sodium or potassium chloride, histidine |
| 07/06/1999 | US5919702 Collecting wharton's jelly from umbilical cords, culturing so that pre-chondrocytes proliferate, isolating pre-chondrocytes which give rise to chondrocytes which produce cartilage tissue for therapeutic use |
| 07/06/1999 | US5919676 Isolated cell concurrently infected with helper adenovirus with packaging signals flanked by recombinase sites and replication/packaging competant helper-dependent vector with deletion to 35,000 base pairs for insertion of exogenous dna |
| 07/06/1999 | US5919660 Human requiem |
| 07/06/1999 | US5919619 Preferentally suppressing gene expression of target proteins by synthesizing and then hybridizing complementary oligonucleotide to subsequence of specific messenger ribonucleic acid in cell |
| 07/06/1999 | US5919614 Mixture of human platelets, physiological saline or plasma, and at least amiloride, adenosine, and sodium nitroprusside; for long term storage stability at low temperature; for transfusions or blood disorders |
| 07/06/1999 | US5919449 Porcine cardiomyocytes and their use in treatment of insufficient cardiac function |
| 07/06/1999 | US5919438 Combinatory immixture of (a) at least one antifungal agent and (b) at least one halogenated antibacterial agent other than a macrolide or pyranoside |
| 07/01/1999 | WO1999032648A1 Recombinant rhabdovirus containing a heterologous fusion protein |
| 07/01/1999 | WO1999032646A1 Equine infectious anaemia virus (eiav) based |
| 07/01/1999 | WO1999032606A2 Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 07/01/1999 | WO1999032516A2 Pharmaceutical compositions containing the long pentraxin ptx3 |
| 07/01/1999 | WO1999032145A1 Delivery of multiple genes to cells using plural adeno-associated viral vectors |
| 07/01/1999 | WO1999032049A1 Acellular matrix grafts: preparation and use |
| 07/01/1999 | WO1999031989A1 Insect repellent and method for producing the same |
| 07/01/1999 | WO1999031982A1 Transvascular delivery of a composition to an extravascular tissue of a mammal |
| 07/01/1999 | WO1999020121A3 Methods for obtaining protein mixtures and control factors from wound granulation, epithelialization or determined blastocyst tissue |
| 07/01/1999 | WO1999018801A9 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 07/01/1999 | DE19830528A1 Multi-layer tablet comprising nutritious substances and microorganisms, and can be stored without cooling |
| 07/01/1999 | DE19757031A1 Mittel zum Repellieren von Insekten und Verfahren zur Herstellung desselben Of the same means for Repellieren of insects and methods for preparing |
| 07/01/1999 | CA2316321A1 Delivery of multiple genes to cells using plural adeno-associated viral vectors |
| 07/01/1999 | CA2315269A1 Equine infectious anaemia virus (eiav) based |
| 07/01/1999 | CA2314905A1 Transvascular delivery of a composition to an extravascular tissue of a mammal |
| 07/01/1999 | CA2309158A1 Acellular matrix grafts: preparation and use |
| 06/30/1999 | EP0925360A1 Angiogenic factor and use thereof in treating cardiovascular disease |
| 06/30/1999 | EP0925356A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
| 06/30/1999 | EP0925309A1 Use of proteins as anti-retroviral agents |
| 06/30/1999 | EP0925305A1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity |
| 06/30/1999 | EP0925304A1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism |
| 06/30/1999 | EP0925077A2 Graft prosthesis, materials and methods |
| 06/30/1999 | EP0925067A1 Composition and method for repairing neurological tissue |
| 06/30/1999 | CN1221349A Cellular vaccines immunotherapeutics and methods for their preparation |
| 06/30/1999 | CN1221347A Medicament for optimising mucosal viscosity and stimulating intestinal function |